219 related articles for article (PubMed ID: 973966)
1. Assessment of antipyrine kinetics by measurement in saliva.
Fraser HS; Mucklow JC; Murray S; Davies DS
Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
Harman AE; Priestly BG; Frewin DB
Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
[TBL] [Abstract][Full Text] [Related]
4. Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose.
Chang RL; Wood AW; Dixon WR; Conney AH; Anderson KE; Eiseman J; Alvares AP
Clin Pharmacol Ther; 1976 Aug; 20(2):219-26. PubMed ID: 947654
[TBL] [Abstract][Full Text] [Related]
5. Application of salivary concentration data to pharmacokinetic studies with antipyrine.
Meffin PJ; Williams RL; Blaschke TF; Rowland M
J Pharm Sci; 1977 Jan; 66(1):135-7. PubMed ID: 833730
[TBL] [Abstract][Full Text] [Related]
6. A sensitive gas-chromatographic assay using a nitrogen-phosphorus detector for determination of antipyrine and aminopyrine in biological fluids.
Shively CA; Simons RJ; Vesell ES
Pharmacology; 1979; 19(5):228-36. PubMed ID: 538077
[TBL] [Abstract][Full Text] [Related]
7. Saliva and plasma clearance of antipyrine as reflectors of liver function.
Luoma PV; Sotaniemi EA
Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
[TBL] [Abstract][Full Text] [Related]
8. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
[TBL] [Abstract][Full Text] [Related]
9. Assessment of antipyrine kinetics from saliva or plasma: influence of age.
Jorquera F; Almar MM; Jimeno A; González-Sastre M; González-Gallego J
J Pharm Biomed Anal; 1995 Aug; 13(9):1141-5. PubMed ID: 8573640
[TBL] [Abstract][Full Text] [Related]
10. Plasma antipyrine half-life can be determined from urine data.
Atiba JO; Taylor G; Pershe RA; Blaschke TF
Br J Clin Pharmacol; 1987 Jun; 23(6):715-9. PubMed ID: 2440468
[TBL] [Abstract][Full Text] [Related]
11. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.
Danhof M; de Groot-van der Vis E; Breimer DD
Pharmacology; 1979; 18(4):210-23. PubMed ID: 461498
[TBL] [Abstract][Full Text] [Related]
12. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
[TBL] [Abstract][Full Text] [Related]
13. A simple method for determination of antipyrine clearance.
Døssing M; Poulsen HE; Andreasen PB; Tygstrup N
Clin Pharmacol Ther; 1982 Sep; 32(3):392-6. PubMed ID: 7105629
[TBL] [Abstract][Full Text] [Related]
14. Antipyrine disposition in milk and saliva of lactating women.
Berlin CM; Vesell ES
Clin Pharmacol Ther; 1982 Jan; 31(1):38-44. PubMed ID: 7053302
[TBL] [Abstract][Full Text] [Related]
15. Ethanol and antipyrine clearance.
Døssing M; Andreasen PB
Clin Pharmacol Ther; 1981 Jul; 30(1):101-4. PubMed ID: 7237890
[No Abstract] [Full Text] [Related]
16. Elimination of antipyrine from saliva as a measure of metabolism in man.
Welch RM; DeAngelis RL; Wingfield M; Farmer TW
Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
[TBL] [Abstract][Full Text] [Related]
17. Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.
Brooks PM; Bell MA; Burns H
Br J Clin Pharmacol; 1976 Oct; 3(5):945-6. PubMed ID: 973995
[No Abstract] [Full Text] [Related]
18. Antipyrine kinetics in liver disease and liver transplantation.
Mehta MU; Venkataramanan R; Burckart GJ; Ptachcinski RJ; Yang SL; Gray JA; Van Thiel DH; Starzl TE
Clin Pharmacol Ther; 1986 Apr; 39(4):372-7. PubMed ID: 3514052
[TBL] [Abstract][Full Text] [Related]
19. Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine.
Vesell ES; Passananti T; Glenwright PA
Pharmacology; 1975; 13(6):481-91. PubMed ID: 1221431
[TBL] [Abstract][Full Text] [Related]
20. The effect of fever on antipyrine metabolism in children.
Forsyth JS; Moreland TA; Rylance GW
Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
